AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookiesPrivacy Policy

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
MCP Server
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

BreakingStocks

Mixed Results for Corning and Travelzoo as Bioventus Sets Earnings Date

First Detected: Oct 27, 2026, 11:09 AM

Last Update: 8 minutes ago

1 update

Event Summary

On October 27, Corning reported a 19% year-over-year increase in core sales to $5.08 billion, exceeding its previous guidance. Meanwhile, Travelzoo saw its revenue grow 3% to $22.9 million, despite reporting an earnings per share loss of $0.20. Additionally, Bioventus announced it will release its third-quarter fiscal year 2026 financial results on November 2, 2026.

Timeline

Latest developmentabout 6 hours ago

Corning Posts Core Sales of $5.081 Billion as Optical Communications Jumps 44%

The company raised its fourth-quarter outlook to about 19% core growth, while generative AI product sales increased more than 100% during the quarter.

Read the full story

Key facts

Corning reported core sales growth of 19% year-over-year to $5.08 billion, exceeding previous guidance.
Travelzoo reported revenue of $22.9 million, up 3% year-over-year, with an earnings per share loss of $0.20.
Bioventus announced it will report its third quarter fiscal year 2026 financial results on November 2, 2026.